Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapyJames R. Berenson, Robert Vescio, Donald Gravenor et al.|Leukemia|2014Cited by 76
A phase I/II study of carfilzomib (CFZ) as a replacement for bortezomib (BTZ) for multiple myeloma (MM) patients (Pts) progressing while receiving a BTZ-containing combination regimen.James R. Berenson, Robert Vescio, Ori Yellin et al.|Journal of Clinical Oncology|2012Cited by 6
Results of a phase I/II study (NCT01365559) of carfilzomib (CFZ) replacing bortezomib (BTZ) in BTZ-containing regimens for BTZ-treated patients (pts) with relapsed and refractory multiple myeloma (MM).James R. Berenson, Robert Vescio, James Hilger et al.|Journal of Clinical Oncology|2013Cited by 3
A Phase 1/2 Study of Carfilzomib As a Replacement for Bortezomib for Multiple Myeloma (MM) Patients (pts) Refractory to a Bortezomib-Containing Combination RegimenJames R. Berenson, Robert Vescio, James Hilger et al.|Blood|2012Cited by 1